BACKGROUND: Exposure of mesothelial cells to peritoneal dialysis fluids (PDF) results in cytoprotective cellular stress responses (CSR) that counteract PDF-induced damage. In this study, we tested the hypothesis that the CSR may be inadequate in relevant models of peritoneal dialysis (PD) due to insufficient levels of glutamine, resulting in increased vulnerability against PDF cytotoxicity. We particularly investigated the role of alanyl-glutamine (Ala-Gln) dipeptide on the cytoprotective PDF stress proteome. METHODS: Adequacy of CSR was investigated in two human in vitro models (immortalized cell line MeT-5A and mesothelial cells derived from peritoneal effluent of uraemic patients) following exposure to heat-sterilized glucose-based PDF (PD4-Dianeal, Baxter) diluted with medium and, in a comparative proteomics approach, at different levels of glutamine ranging from depletion (0 mM) via physiological (0.7 mM) to pharmacological levels (8 mM administered as Ala-Gln). RESULTS: Despite severe cellular injury, expression of cytoprotective proteins was dampened upon PDF exposure at physiological glutamine levels, indicating an inadequate CSR. Depletion of glutamine aggravated cell injury and further reduced the CSR, whereas addition of Ala-Gln at pharmacological level restored an adequate CSR, decreasing cellular damage in both PDF exposure systems. Ala-Gln specifically stimulated chaperoning activity, and cytoprotective processes were markedly enhanced in the PDF stress proteome. CONCLUSIONS: Taken together, this study demonstrates an inadequate CSR of mesothelial cells following PDF exposure associated with low and physiological levels of glutamine, indicating a new and potentially relevant pathomechanism. Supplementation of PDF with pharmacological doses of Ala-Gln restored the cytoprotective stress proteome, resulting in improved resistance of mesothelial cells to exposure to PDF. Future work will study the clinical relevance of CSR-mediated cytoprotection.
RCT Entities:
BACKGROUND: Exposure of mesothelial cells to peritoneal dialysis fluids (PDF) results in cytoprotective cellular stress responses (CSR) that counteract PDF-induced damage. In this study, we tested the hypothesis that the CSR may be inadequate in relevant models of peritoneal dialysis (PD) due to insufficient levels of glutamine, resulting in increased vulnerability against PDFcytotoxicity. We particularly investigated the role of alanyl-glutamine (Ala-Gln) dipeptide on the cytoprotective PDF stress proteome. METHODS: Adequacy of CSR was investigated in two human in vitro models (immortalized cell line MeT-5A and mesothelial cells derived from peritoneal effluent of uraemic patients) following exposure to heat-sterilized glucose-based PDF (PD4-Dianeal, Baxter) diluted with medium and, in a comparative proteomics approach, at different levels of glutamine ranging from depletion (0 mM) via physiological (0.7 mM) to pharmacological levels (8 mM administered as Ala-Gln). RESULTS: Despite severe cellular injury, expression of cytoprotective proteins was dampened upon PDF exposure at physiological glutamine levels, indicating an inadequate CSR. Depletion of glutamine aggravated cell injury and further reduced the CSR, whereas addition of Ala-Gln at pharmacological level restored an adequate CSR, decreasing cellular damage in both PDF exposure systems. Ala-Gln specifically stimulated chaperoning activity, and cytoprotective processes were markedly enhanced in the PDF stress proteome. CONCLUSIONS: Taken together, this study demonstrates an inadequate CSR of mesothelial cells following PDF exposure associated with low and physiological levels of glutamine, indicating a new and potentially relevant pathomechanism. Supplementation of PDF with pharmacological doses of Ala-Gln restored the cytoprotective stress proteome, resulting in improved resistance of mesothelial cells to exposure to PDF. Future work will study the clinical relevance of CSR-mediated cytoprotection.
Authors: Dagmar Csaicsich; Anton M Lichtenauer; Andreas Vychytil; David C Kasper; Rebecca Herzog; Christoph Aufricht; Klaus Kratochwill Journal: Perit Dial Int Date: 2015 Sep-Oct Impact factor: 1.756
Authors: Rebecca Herzog; Thorsten O Bender; Andreas Vychytil; Katarzyna Bialas; Christoph Aufricht; Klaus Kratochwill Journal: J Am Soc Nephrol Date: 2014-05-22 Impact factor: 10.121
Authors: Elena L Rudashevskaya; Roberto Sacco; Klaus Kratochwill; Marie L Huber; Matthias Gstaiger; Giulio Superti-Furga; Keiryn L Bennett Journal: Nat Protoc Date: 2012-12-13 Impact factor: 13.491
Authors: Klaus Kratochwill; Michael Boehm; Rebecca Herzog; Katharina Gruber; Anton Michael Lichtenauer; Lilian Kuster; Dagmar Csaicsich; Andreas Gleiss; Seth L Alper; Christoph Aufricht; Andreas Vychytil Journal: PLoS One Date: 2016-10-21 Impact factor: 3.240
Authors: Rebecca Herzog; Michael Boehm; Markus Unterwurzacher; Anja Wagner; Katja Parapatics; Peter Májek; André C Mueller; Anton Lichtenauer; Keiryn L Bennett; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill Journal: Mol Cell Proteomics Date: 2017-12-04 Impact factor: 5.911
Authors: Rebecca Herzog; Silvia Tarantino; András Rudolf; Christoph Aufricht; Klaus Kratochwill; Janusz Witowski Journal: Biomed Res Int Date: 2015-11-10 Impact factor: 3.411
Authors: Klaus Kratochwill; Thorsten O Bender; Anton M Lichtenauer; Rebecca Herzog; Silvia Tarantino; Katarzyna Bialas; Achim Jörres; Christoph Aufricht Journal: Biomed Res Int Date: 2015-10-01 Impact factor: 3.411
Authors: Mario Bonomini; Francesc E Borras; Maribel Troya-Saborido; Laura Carreras-Planella; Lorenzo Di Liberato; Arduino Arduini Journal: Int J Mol Sci Date: 2020-07-31 Impact factor: 5.923